Herbert H. Seltzman

Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists

Brian F. Thomas, Anne F. Gilliam, David F. Burch et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 242 citations

Medicine, Medicinal Chemistry, Pharmacology +16

N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) Interaction with LYS 3.28(192) Is Crucial for Its Inverse Agonism at the Cannabinoid CB1 Receptor

Dow P. Hurst, Diane L. Lynch, Judy Barnett‐Norris et al. · Molecular Pharmacology · 2002 · 160 citations

Medicine, Neuroscience, Pharmacology +14

Targeting of the Orphan Receptor GPR35 by Pamoic Acid: A Potent Activator of Extracellular Signal-Regulated Kinase and β-Arrestin2 with Antinociceptive Activity

Pingwei Zhao, Haleli Sharir, Ankur Kapur et al. · Molecular Pharmacology · 2010 · 139 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Identification of the GPR55 Antagonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands

Evangelia Kotsikorou, Haleli Sharir, Derek M. Shore et al. · Biochemistry · 2013 · 102 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and Structure−Activity Relationships of Amide and Hydrazide Analogues of the Cannabinoid CB₁ Receptor Antagonist <i>N</i>-(Piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1<i>H</i>-pyrazole-3-carboxamide (SR141716)

Ma. Elena Y. Francisco, Herbert H. Seltzman, Anne F. Gilliam et al. · Journal of Medicinal Chemistry · 2002 · 87 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14